Skip to main content
. 2021 Jun 28;2021(6):CD004135. doi: 10.1002/14651858.CD004135.pub4

Roehrborn 1997.

Methods Randomized controlled trial
Participants Men with benign prostatic hyperplasia
Interventions Dornier Urowave TUMT device
Outcomes AUA‐SI, Qmax, PSA, BPH QoL, adverse events, prostate volume
Notes Presumably a secondary report of Roehrborn 1998 (this abstract reported 205 participants while the included study reported 220). Full‐text not available.